Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
United Therapeutics
UTHR
|
+$473M |
| 2 |
Intel
INTC
|
+$412M |
| 3 |
Amazon
AMZN
|
+$396M |
| 4 |
Microsoft
MSFT
|
+$385M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$373M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$309M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$283M |
| 3 |
TSMC
TSM
|
+$246M |
| 4 |
NVIDIA
NVDA
|
+$212M |
| 5 |
Bank of America
BAC
|
+$191M |
Sector Composition
| 1 | Technology | 29.65% |
| 2 | Consumer Discretionary | 10.15% |
| 3 | Healthcare | 9.29% |
| 4 | Financials | 8.19% |
| 5 | Communication Services | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Acrivon Therapeutics
ACRV
$48.8M
| $29.5K | ﹤0.01% |
5,082
+546
| +12% | +$3.17K |
|
3952
Crawford & Co Class A
CRD.A
$540M
| $29.5K | ﹤0.01% |
3,411
+916
| +37% | +$7.91K |
|
3953
FibroBiologics
FBLG
$23.7M
| $29.5K | ﹤0.01% |
5,906
-24,513
| -81% | -$122K |
|
3954
Lifecore Biomedical
LFCR
$291M
| $29.5K | ﹤0.01% |
5,743
-122,809
| -96% | -$630K |
|
3955
Schwab Fundamental US Small Company Index ETF
FNDA
$9.13B
| $29.4K | ﹤0.01% |
1,072
-872
| -45% | -$23.9K |
|
3956
Invesco S&P 500 Pure Value ETF
RPV
$1.37B
| $29.3K | ﹤0.01% |
351
| – | – |
|
3957
ProShares UltraShort QQQ
QID
$277M
| $29.1K | ﹤0.01% |
760
-150
| -16% | -$5.75K |
|
|
NAGE
3958
Niagen Bioscience, Inc. Common Stock
NAGE
$767M
| $29.1K | ﹤0.01% |
10,652
-52,217
| -83% | -$143K |
|
3959
First National Corp
FXNC
$211M
| $29K | ﹤0.01% |
1,910
-912
| -32% | -$13.9K |
|
3960
GrowGeneration
GRWG
$92.6M
| $29K | ﹤0.01% |
13,475
+1,168
| +9% | +$2.51K |
|
3961
Lunai Bioworks Inc. Common Stock
RENB
$46.3M
| $28.8K | ﹤0.01% |
16,442
-171,012
| -91% | -$299K |
|
3962
Cadiz
CDZI
$312M
| $28.6K | ﹤0.01% |
9,267
+2,547
| +38% | +$7.87K |
|
3963
Solid Biosciences
SLDB
$413M
| $28.6K | ﹤0.01% |
5,041
-42,671
| -89% | -$242K |
|
3964
Candel Therapeutics
CADL
$270M
| $28.5K | ﹤0.01% |
+4,598
| New | +$28.5K |
|
3965
Plains GP Holdings
PAGP
$3.69B
| $28.4K | ﹤0.01% |
1,508
-463
| -23% | -$8.71K |
|
3966
Northern Technologies International Corp
NTIC
$74.8M
| $28.4K | ﹤0.01% |
+1,712
| New | +$28.4K |
|
3967
Aegon
AEG
$12.1B
| $28.1K | ﹤0.01% |
4,589
+396
| +9% | +$2.43K |
|
3968
Nuveen ESG Mid-Cap Value ETF
NUMV
$403M
| $27.8K | ﹤0.01% |
843
+463
| +122% | +$15.3K |
|
3969
Rallybio
RLYB
$24.7M
| $27.8K | ﹤0.01% |
20,751
+14,403
| +227% | +$19.3K |
|
3970
Perma-Fix Environmental Services
PESI
$151M
| $27.7K | ﹤0.01% |
2,737
-4,686
| -63% | -$47.5K |
|
3971
WisdomTree International LargeCap Dividend Fund
DOL
$667M
| $27.7K | ﹤0.01% |
546
| – | – |
|
3972
BlackSky Technology
BKSY
$617M
| $27.6K | ﹤0.01% |
3,227
+381
| +13% | +$3.26K |
|
3973
NACCO Industries
NC
$306M
| $27.6K | ﹤0.01% |
998
+75
| +8% | +$2.08K |
|
3974
Energy Vault
NRGV
$329M
| $27.5K | ﹤0.01% |
28,970
+4,509
| +18% | +$4.28K |
|
3975
SWK Holdings
SWKH
$177M
| $27.5K | ﹤0.01% |
2,041
+577
| +39% | +$7.77K |
|